Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	31.42	80.80	61.48
Graham Fair Price	6.63	37.42	35.09
PEG	23.87	3.23	2.61
Price/Book	6.40	3.97	3.73
Price/Cash Flow	-93.20	111.63	1641.68
Prices/Earnings	4.46	23.70	22.69
Price/Sales	6.59	11.07	10.39
Price/FCF	-93.20	111.63	1641.68
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	8.03	0.28	0.26
Operating Margin	-21.56	0.11	0.14
ROA	2.50	0.02	0.02
ROE	0.04	0.04	1.86
ROIC	0.03	0.02	-23.01
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.10	0.02	319.83
Dividends QOQ	< 0.005	0.14	4682.33
EBIT QOQ	< 0.005	-0.17	-32670.29
EPS QOQ	0.09	0.07	-15.67
FCF QOQ	-0.96	15.64	1525.01
Revenue QOQ	0.01	0.06	397.06
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	86.49	86.92	0.49
Days Sales Outstanding (DSO)	90.31	93.15	3.15
Inventory Turnover	1.04	1.04	-0.49
Debt/Capitalization	0.25	0.25	0.67
Quick Ratio	1.60	1.71	6.59
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	36.49	38.55	5.65
Cash	2.40	5.24	118.09
Capex	-0.70	-0.24	65.58
Free Cash Flow	0.08	1.37	1553.27
Revenue	13.11	13.82	5.47
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	2.65	2.62	-1.28
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	4.17	4.13	-1.05
Naive Interpretation	Member

06 - Financial Health · Bad

Rating